STOCK TITAN

CYABRA INC Financials

CYAB
Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows CYABRA INC (CYAB) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CYAB FY2025

Accumulated losses have pushed equity below zero, so this filing says more about capital strain than operating scale.

Because net loss and operating loss are both -$156K, the reported deficit appears to come from the core cost structure rather than financing or tax effects. That same loss reconciles with diluted EPS of -$156.35 on only 1000 shares, which makes per-share figures unusually sensitive to even small changes in results.

With total equity at -$210K and retained earnings also at -$210K, the balance-sheet deficit appears to be almost entirely the accumulation of past losses rather than other equity adjustments. Current liabilities of $210K matching that deficit means the reported balance-sheet support is coming from obligations instead of residual shareholder capital.

Some figures from recent filings were inconsistent and were omitted from this summary.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 0 / 100
Financial Profile 0/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of CYABRA INC's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Liquidity
0

CYABRA INC's current ratio of 0.03 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
N/A
EBITDA
N/A
Net Income
-$156K

CYABRA INC reported -$156K in net income in fiscal year 2025.

EPS (Diluted)
$-156.35

CYABRA INC earned $-156.35 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$294K

CYABRA INC held $294K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
1,000

CYABRA INC had 1,000 shares outstanding in fiscal year 2025.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
N/A

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

CYAB Income Statement

Metric Q1'26 Q4'25 Q1'25 Q4'24
Revenue $1.4M N/A $1.3M N/A
Cost of Revenue $192K N/A $196K N/A
Gross Profit $1.2M N/A $1.1M N/A
R&D Expenses $5.5M N/A $1.9M N/A
SG&A Expenses $6.3M N/A $1.5M N/A
Operating Income -$11.8M N/A -$4.0M N/A
Interest Expense $173K N/A N/A N/A
Income Tax N/A N/A N/A N/A
Net Income -$10.8M N/A -$3.3M N/A
EPS (Diluted) $-3.10 N/A $-1.47 N/A

CYAB Balance Sheet

Metric Q1'26 Q4'25 Q1'25 Q4'24
Total Assets $4.5M+210.5% $1.5M N/A N/A
Current Assets $3.8M+411.8% $737K N/A N/A
Cash & Equivalents $3.1M+961.9% $294K-57.3% $688K-27.3% $946K
Inventory N/A N/A N/A N/A
Accounts Receivable $216K-19.7% $269K N/A N/A
Goodwill N/A N/A N/A N/A
Total Liabilities $16.6M-60.1% $41.5M N/A N/A
Current Liabilities $16.4M-35.8% $25.5M N/A $54K
Long-Term Debt N/A N/A N/A N/A
Total Equity -$12.0M+69.9% -$40.0M-23.8% -$32.3M-6.3% -$30.4M
Retained Earnings -$58.1M-22.7% -$47.4M N/A -$54K

CYAB Financial Ratios

Metric Q1'26 Q4'25 Q1'25 Q4'24
Gross Margin 86.4% N/A 84.4% N/A
Operating Margin -835.6% N/A -320.5% N/A
Net Margin -761.1% N/A -263.0% N/A
Return on Equity N/A N/A N/A N/A
Return on Assets -237.9% N/A N/A N/A
Current Ratio 0.23+0.2 0.03 N/A N/A
Debt-to-Equity -1.38-0.3 -1.04 N/A N/A
FCF Margin -184.0% N/A -102.0% N/A

Note: Shareholder equity is negative (-$40.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.03), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

No, CYABRA INC (CYAB) reported a net income of -$156K in fiscal year 2025.

CYABRA INC (CYAB) reported diluted earnings per share of $-156.35 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

CYABRA INC (CYAB) had $1.5M in total assets as of fiscal year 2025, including both current and long-term assets.

CYABRA INC (CYAB) had 1,000 shares outstanding as of fiscal year 2025.

CYABRA INC (CYAB) had a current ratio of 0.03 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

CYABRA INC (CYAB) had a debt-to-equity ratio of -1.04 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

CYABRA INC (CYAB) had a return on assets of -10.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

CYABRA INC (CYAB) has negative shareholder equity of -$40.0M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

CYABRA INC (CYAB) scores 0 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top